University of Wisconsin, Madison: COVID-19 trials

The registry lists 13 COVID-19 studies with University of Wisconsin, Madison as lead sponsor. 0 are open to participants now and 9 have results posted.

Early Phase 1 1Phase 2 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed PopulationsCompletedNCT06027229Phase 2Results posted
• Inpatient COVID-19 Lollipop StudyTerminatedNCT05801341Not applicableResults posted
• Smartphone Intervention for Overdose and COVID-19CompletedNCT05518461Not applicableResults posted
• Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19CompletedNCT05419128Not applicableResults posted
• Safe and Healthy SchoolsCompletedNCT05105789Not applicableResults posted
• BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19)TerminatedNCT05087524Not applicableResults posted
• ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and StaffCompletedNCT04899245Not applicableResults posted
• ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School AttendanceCompletedNCT04895085Not applicableResults posted
• Rapid, Onsite COVID-19 DetectionCompletedNCT04460690Not applicableResults posted
• Lollipop COVID-19 Testing StudyWithdrawnNCT05472077Not applicable
• Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel DiseaseCompletedNCT04818892
• COVID EHR COHORT at the University of WisconsinCompletedNCT04506528
• SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral SheddingCompletedNCT04478019Early Phase 1